vs

Side-by-side financial comparison of OptimizeRx Corp (OPRX) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $22.7M, roughly 1.4× R F INDUSTRIES LTD). OptimizeRx Corp runs the higher net margin — 15.6% vs 0.8%, a 14.8% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -0.2%). OptimizeRx Corp produced more free cash flow last quarter ($7.1M vs $2.0M). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs 28.0%).

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

OPRX vs RFIL — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.4× larger
OPRX
$32.2M
$22.7M
RFIL
Growing faster (revenue YoY)
RFIL
RFIL
+23.2% gap
RFIL
22.9%
-0.2%
OPRX
Higher net margin
OPRX
OPRX
14.8% more per $
OPRX
15.6%
0.8%
RFIL
More free cash flow
OPRX
OPRX
$5.0M more FCF
OPRX
$7.1M
$2.0M
RFIL
Faster 2-yr revenue CAGR
RFIL
RFIL
Annualised
RFIL
29.8%
28.0%
OPRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPRX
OPRX
RFIL
RFIL
Revenue
$32.2M
$22.7M
Net Profit
$5.0M
$173.0K
Gross Margin
74.8%
36.8%
Operating Margin
26.6%
4.0%
Net Margin
15.6%
0.8%
Revenue YoY
-0.2%
22.9%
Net Profit YoY
6535.9%
172.7%
EPS (diluted)
$0.27
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPRX
OPRX
RFIL
RFIL
Q4 25
$32.2M
$22.7M
Q3 25
$26.1M
$19.8M
Q2 25
$29.2M
$18.9M
Q1 25
$21.9M
$19.2M
Q4 24
$32.3M
$18.5M
Q3 24
$21.3M
$16.8M
Q2 24
$18.8M
$16.1M
Q1 24
$19.7M
$13.5M
Net Profit
OPRX
OPRX
RFIL
RFIL
Q4 25
$5.0M
$173.0K
Q3 25
$779.0K
$392.0K
Q2 25
$1.5M
$-245.0K
Q1 25
$-2.2M
$-245.0K
Q4 24
$-78.0K
$-238.0K
Q3 24
$-9.1M
$-705.0K
Q2 24
$-4.0M
$-4.3M
Q1 24
$-6.9M
$-1.4M
Gross Margin
OPRX
OPRX
RFIL
RFIL
Q4 25
74.8%
36.8%
Q3 25
67.2%
34.0%
Q2 25
63.8%
31.5%
Q1 25
60.9%
29.8%
Q4 24
68.1%
31.3%
Q3 24
63.1%
29.5%
Q2 24
62.2%
29.9%
Q1 24
62.0%
24.5%
Operating Margin
OPRX
OPRX
RFIL
RFIL
Q4 25
26.6%
4.0%
Q3 25
7.9%
3.6%
Q2 25
10.9%
0.6%
Q1 25
-9.6%
0.3%
Q4 24
11.2%
0.5%
Q3 24
-40.2%
-2.5%
Q2 24
-19.9%
-2.6%
Q1 24
-25.5%
-15.5%
Net Margin
OPRX
OPRX
RFIL
RFIL
Q4 25
15.6%
0.8%
Q3 25
3.0%
2.0%
Q2 25
5.2%
-1.3%
Q1 25
-10.0%
-1.3%
Q4 24
-0.2%
-1.3%
Q3 24
-42.8%
-4.2%
Q2 24
-21.3%
-26.7%
Q1 24
-35.0%
-10.1%
EPS (diluted)
OPRX
OPRX
RFIL
RFIL
Q4 25
$0.27
$0.01
Q3 25
$0.04
$0.04
Q2 25
$0.08
$-0.02
Q1 25
$-0.12
$-0.02
Q4 24
$0.00
$-0.02
Q3 24
$-0.50
$-0.07
Q2 24
$-0.22
$-0.41
Q1 24
$-0.38
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPRX
OPRX
RFIL
RFIL
Cash + ST InvestmentsLiquidity on hand
$23.4M
$5.1M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$128.3M
$35.2M
Total Assets
$176.9M
$73.0M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPRX
OPRX
RFIL
RFIL
Q4 25
$23.4M
$5.1M
Q3 25
$19.5M
$3.0M
Q2 25
$16.6M
$3.6M
Q1 25
$16.6M
$1.3M
Q4 24
$13.4M
$839.0K
Q3 24
$16.1M
$1.8M
Q2 24
$1.4M
Q1 24
$4.5M
Total Debt
OPRX
OPRX
RFIL
RFIL
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
OPRX
OPRX
RFIL
RFIL
Q4 25
$128.3M
$35.2M
Q3 25
$122.3M
$34.8M
Q2 25
$119.3M
$34.2M
Q1 25
$116.3M
$34.2M
Q4 24
$117.0M
$34.1M
Q3 24
$114.5M
$34.1M
Q2 24
$121.0M
$34.6M
Q1 24
$122.5M
$38.7M
Total Assets
OPRX
OPRX
RFIL
RFIL
Q4 25
$176.9M
$73.0M
Q3 25
$170.3M
$73.2M
Q2 25
$169.3M
$72.7M
Q1 25
$167.8M
$70.4M
Q4 24
$171.2M
$71.0M
Q3 24
$165.2M
$71.9M
Q2 24
$172.9M
$72.8M
Q1 24
$176.4M
$79.1M
Debt / Equity
OPRX
OPRX
RFIL
RFIL
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPRX
OPRX
RFIL
RFIL
Operating Cash FlowLast quarter
$7.1M
$2.1M
Free Cash FlowOCF − Capex
$7.1M
$2.0M
FCF MarginFCF / Revenue
22.0%
9.0%
Capex IntensityCapex / Revenue
0.0%
0.3%
Cash ConversionOCF / Net Profit
1.41×
12.13×
TTM Free Cash FlowTrailing 4 quarters
$18.7M
$4.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPRX
OPRX
RFIL
RFIL
Q4 25
$7.1M
$2.1M
Q3 25
$3.2M
$-311.0K
Q2 25
$4.6M
$2.2M
Q1 25
$3.9M
$601.0K
Q4 24
$198.0K
$-244.0K
Q3 24
$1.8M
$2.4M
Q2 24
$782.0K
$197.0K
Q1 24
$2.1M
$840.0K
Free Cash Flow
OPRX
OPRX
RFIL
RFIL
Q4 25
$7.1M
$2.0M
Q3 25
$3.2M
$-419.0K
Q2 25
$4.6M
$2.2M
Q1 25
$3.8M
$574.0K
Q4 24
$181.0K
$-418.0K
Q3 24
$1.8M
$2.1M
Q2 24
$737.0K
$28.0K
Q1 24
$2.1M
$697.0K
FCF Margin
OPRX
OPRX
RFIL
RFIL
Q4 25
22.0%
9.0%
Q3 25
12.2%
-2.1%
Q2 25
15.6%
11.4%
Q1 25
17.5%
3.0%
Q4 24
0.6%
-2.3%
Q3 24
8.3%
12.6%
Q2 24
3.9%
0.2%
Q1 24
10.6%
5.2%
Capex Intensity
OPRX
OPRX
RFIL
RFIL
Q4 25
0.0%
0.3%
Q3 25
0.0%
0.5%
Q2 25
0.0%
0.2%
Q1 25
0.1%
0.1%
Q4 24
0.1%
0.9%
Q3 24
0.1%
1.5%
Q2 24
0.2%
1.0%
Q1 24
0.2%
1.1%
Cash Conversion
OPRX
OPRX
RFIL
RFIL
Q4 25
1.41×
12.13×
Q3 25
4.11×
-0.79×
Q2 25
2.98×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPRX
OPRX

Segment breakdown not available.

RFIL
RFIL

US$20.9M92%
Non Us$1.8M8%

Related Comparisons